Furthermore, our KEGG pathway enrichment analysis in LNCaP/AR/shTP53/shRB1 cells revealed a correlation between ELAVL3 deficiency and the reduction of several oncogenic pathways (MAPK, NFκB, Small cell lung cancer, and TNFα pathways) and neuronal-related pathways (GABAergic synapse, serotonergic synapse, glutamatergic synapse, and cholinergic synapse) (Fig. 2g). Here, ELAVL3 is linked to small cell lung carcinoma.